Dose-escalating induction chemotherapy supported by lenograstim preceding high-dose consolidation chemotherapy for advanced breast cancer. Selection of the most acceptable regimen to induce maximal tumor response and investigation of the optimal time to collect peripheral blood progenitor cells for haematological rescue after high-dose consolidation chemotherapy.
Authors
Van Hoef, M EBaumann, Irith
Lange, C
Luft, T
De Wynter, Erika A
Ranson, Malcolm R
Morgenstern, Godfrey R
Yvers, A
Dexter, T Michael
Testa, Nydia G
Howell, Anthony
Affiliation
CRC Dept. of Medical Oncology, Christie Hospital, Manchester U.K.Issue Date
1994-03